Vanda Pharmaceuticals SG&A Expense (TTM) Insights

Vanda Pharmaceuticals Inc (VNDA)

4.67 -0.07 (-1.48%) USD | NASDAQ | Sep 27, 16:00

4.675 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2005. Upgrade now.

Date	Value
June 30, 2024	117.94M
March 31, 2024	106.86M
December 31, 2023	112.88M
September 30, 2023	122.05M
June 30, 2023	127.14M
March 31, 2023	131.74M
December 31, 2022	136.48M
September 30, 2022	137.15M
June 30, 2022	139.75M
March 31, 2022	135.10M
December 31, 2021	124.05M
September 30, 2021	126.17M
June 30, 2021	127.72M
March 31, 2021	133.29M
December 31, 2020	140.51M
September 30, 2020	141.96M
June 30, 2020	138.18M
March 31, 2020	135.73M
December 31, 2019	129.74M
September 30, 2019	117.64M
June 30, 2019	113.47M
March 31, 2019	109.96M
December 31, 2018	105.75M
September 30, 2018	111.88M
June 30, 2018	116.96M

Date	Value
March 31, 2018	120.37M
December 31, 2017	123.84M
September 30, 2017	116.70M
June 30, 2017	107.48M
March 31, 2017	100.79M
December 31, 2016	99.79M
September 30, 2016	104.76M
June 30, 2016	101.31M
March 31, 2016	95.02M
December 31, 2015	84.53M
September 30, 2015	72.97M
June 30, 2015	65.80M
March 31, 2015	75.56M
December 31, 2014	84.64M
September 30, 2014	77.25M
June 30, 2014	71.70M
March 31, 2014	48.82M
December 31, 2013	25.08M
September 30, 2013	19.01M
June 30, 2013	16.42M
March 31, 2013	14.76M
December 31, 2012	14.52M
September 30, 2012	14.00M
June 30, 2012	13.57M
March 31, 2012	12.54M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

106.86M

Minimum

Mar 2024

141.96M

Maximum

Sep 2020

129.10M

Average

130.74M

Median

SG&A Expense (TTM) Benchmarks